Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 12 studies | 53% ± 24% | |
| GABAergic neuron | 9 studies | 48% ± 24% | |
| amacrine cell | 7 studies | 29% ± 6% | |
| neuron | 6 studies | 28% ± 8% | |
| interneuron | 6 studies | 51% ± 26% | |
| oligodendrocyte precursor cell | 6 studies | 21% ± 6% | |
| retinal ganglion cell | 5 studies | 31% ± 14% | |
| retina horizontal cell | 5 studies | 27% ± 6% | |
| granule cell | 4 studies | 30% ± 8% | |
| GABAergic interneuron | 3 studies | 44% ± 9% | |
| rod bipolar cell | 3 studies | 19% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 12 studies | 38% ± 22% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 99% | 6148.84 | 2610 / 2642 | 90% | 9.88 | 635 / 705 |
| adrenal gland | 95% | 1260.55 | 245 / 258 | 77% | 15.77 | 176 / 230 |
| ovary | 98% | 2892.84 | 176 / 180 | 25% | 0.73 | 108 / 430 |
| prostate | 51% | 445.42 | 125 / 245 | 57% | 1.47 | 288 / 502 |
| uterus | 31% | 221.56 | 53 / 170 | 12% | 0.39 | 56 / 459 |
| esophagus | 26% | 219.34 | 382 / 1445 | 9% | 0.23 | 17 / 183 |
| stomach | 25% | 266.67 | 89 / 359 | 9% | 0.35 | 25 / 286 |
| intestine | 17% | 122.77 | 169 / 966 | 4% | 0.11 | 21 / 527 |
| pancreas | 0% | 0 | 0 / 328 | 21% | 0.96 | 38 / 178 |
| lung | 0% | 0 | 0 / 578 | 15% | 0.54 | 169 / 1155 |
| heart | 9% | 61.75 | 81 / 861 | 0% | 0 | 0 / 0 |
| liver | 0% | 0 | 0 / 226 | 8% | 0.40 | 31 / 406 |
| thymus | 0% | 0 | 0 / 653 | 6% | 0.12 | 36 / 605 |
| bladder | 0% | 0 | 0 / 21 | 5% | 0.11 | 25 / 504 |
| breast | 2% | 8.64 | 7 / 459 | 3% | 0.07 | 32 / 1118 |
| eye | 0% | 0 | 0 / 0 | 3% | 0.07 | 2 / 80 |
| skin | 0% | 0.85 | 2 / 1809 | 2% | 0.05 | 8 / 472 |
| kidney | 0% | 0 | 0 / 89 | 1% | 0.03 | 9 / 901 |
| blood vessel | 0% | 0.79 | 2 / 1335 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_1904717 | Biological process | regulation of AMPA glutamate receptor clustering |
| GO_0099072 | Biological process | regulation of postsynaptic membrane neurotransmitter receptor levels |
| GO_0051966 | Biological process | regulation of synaptic transmission, glutamatergic |
| GO_1900449 | Biological process | regulation of glutamate receptor signaling pathway |
| GO_0005575 | Cellular component | cellular_component |
| GO_0045202 | Cellular component | synapse |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0044877 | Molecular function | protein-containing complex binding |
| GO_0045505 | Molecular function | dynein intermediate chain binding |
| GO_0003674 | Molecular function | molecular_function |
| Gene name | FRRS1L |
| Protein name | DOMON domain-containing protein FRRS1L (Brain protein CG-6) (Ferric-chelate reductase 1-like protein) Ferric chelate reductase 1 like |
| Synonyms | C9orf4 |
| Description | FUNCTION: Important modulator of glutamate signaling pathway. . |
| Accessions | A0A2R8Y5Y6 ENST00000644747.1 ENST00000642299.1 A0A2R8YDG8 ENST00000644736.1 Q9P0K9 ENST00000561981.5 A0A2R8Y4E4 |